Tests home breathing guidance by smart devices for chronic obstructive pulmonary disease
Tests guided breathing exercises at home in adults with chronic obstructive pulmonary disease.
Plain-language title generated from the registry record
Registry title: Clinical Study on Improving Exercise Capacity in Chronic Obstructive Pulmonary Disease Through Smart IoT-Remote Home Breathing Guidance
Key facts
- Where
- Zhengzhou, ChinaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 40 and 80 years old?
Source: NCT06963333, who can take part
Where in China
- The First Affiliated Hospital of Henan University of Traditional Chinese MedicineZhengzhou, ChinaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Henan University of Traditional Chinese Medicine
- Trial code
- NCT06963333
- Record updated
- 9 May 2025
- Original description
This study aims to evaluate the clinical efficacy of breath-guided improvement of COPD exercise ability, establish a breath-guided rehabilitation program of intelligent iot and remote home, improve COPD exercise ability, reduce acute exacerbation, and form high-quality clinical evidence.Read full original descriptionShow less
Clinical Study on Improving Exercise Capacity in Chronic Obstructive Pulmonary Disease Through Smart IoT-Remote Home Breathing Guidance: A Multicenter, Randomized, Controlled Clinical Trial
This study aims to evaluate the clinical efficacy of breath-guided improvement of COPD exercise ability, establish a breath-guided rehabilitation program of intelligent iot and remote home, improve COPD exercise ability, reduce acute exacerbation, and form high-quality clinical evidence.
Inclusion: Patients with COPD in stable stage; Patients with grade 2 to 4 lung function; Age 40~80 years old; Be able to use smart phones, computers and other devices independently or with the help of family members during home training; Volunteer for treatment and sign an informed consent form.
Exclusion: Tumor patients who have undergone resection, radiation, and chemotherapy within 5 years; Participants who were participating in other clinical trials within 1 month prior to enrollment; Delirious, dementia, all kinds of mental illness; Patients with severe visual impairment that cannot be improved or who have epilepsy or vertigo and cannot use VR devices; Patients with progressive neuromuscular disease; Patients with pulmonary abscess, pulmonary interstitial fibrosis, active pulmonary tuberculosis, bronchiectasis, pulmonary embolism and other pulmonary diseases; Patients with severe cardiovascular and cerebrovascular diseases (malignant arrhythmia, unstable angina pectoris, acute myocardial infarction, grade 3 or above cardiac function, stroke, cerebral hemorrhage, etc.); Patients with severe liver disease (cirrhosis, portal hypertension and bleeding caused by esophageal and gastric varices, etc.) and severe kidney disease (dialysis, kidney transplantation, etc.); Pregnant or lactating women and patients with recent pregnancy plans; Patients with severe osteoarthropathy or osteoporosis, unstable fractures; People who stay in bed for a long time for various reasons.